학술논문
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)
Document Type
Article
Author
Source
In Annals of Oncology April 2018 29(4):1004-1009
Subject
Language
ISSN
0923-7534